TNF Inhibitor Drugs Market Set for More Growth with Amgen, AbbVie, GlaxoSmithKline
The Global TNF Inhibitor Drugs Market was valued at USD 10161.11 Million in 2023 and is expected to reach USD 12658.33 Million by 2029, growing at a CAGR of 2.78% during 2023-2029.
View full press release